[Antibiotic treatment in myasthenia gravis].
D000293:Adolescent; D000368:Aged; D000617:Aminoglycosides / Q000009:adverse effects; D000667:Ampicillin / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D002701:Chloramphenicol / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007239:Infections / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000150:complications*; D009388:Neostigmine / Q000008:administration & dosage; D013449:Sulfonamides / Q000008:administration & dosage
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D013449:Sulfonamides; D009388:Neostigmine; D002701:Chloramphenicol; D000667:Ampicillin